Related Articles
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin
Transcriptional regulation of FoxM1 by HIF‑1α mediates hypoxia‑induced EMT in prostate cancer
Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression
Overexpression of forkhead box M1 and urokinase‑type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis